We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer and BioNTech Raise Vaccine Production Bar to Two Billion Doses in 2021
Pfizer and BioNTech Raise Vaccine Production Bar to Two Billion Doses in 2021
Pfizer and BioNTech now anticipate manufacturing up to 2 billion doses of their highly effective COVID-19 vaccine by the end of the year as vaccination efforts ramp up and demand for shots increases around the globe.